Medicare covers a broad range of Parkinson’s disease services, from routine neurologist visits and prescription medications to physical therapy, deep brain stimulation surgery, mobility equipment, and home health care. The specifics depend on which part of Medicare applies, and your out-of-pocket costs vary by service type. Here’s a practical breakdown of what’s covered and what to expect.
Doctor Visits and Diagnostic Services
Medicare Part B covers outpatient visits with neurologists and movement disorder specialists, including the initial evaluation where a diagnosis is made based on cardinal features like tremor, rigidity, or slowed movement. Follow-up visits to monitor symptom progression and adjust treatment are also covered. After meeting the annual Part B deductible ($257 in 2025), you typically pay 20% of the Medicare-approved amount for these visits.
Neuropsychological testing is covered when there’s a suspected cognitive or mental health issue that needs formal assessment, which matters for Parkinson’s because depression, anxiety, and cognitive decline are common as the disease progresses. Simple screening tools like the Mini-Mental Status Exam aren’t billed separately since they’re considered part of a standard office visit. More comprehensive testing requires a clinical reason beyond routine screening.
Prescription Drug Coverage Under Part D
The medications most central to Parkinson’s treatment, including dopamine precursors (like carbidopa-levodopa) and non-ergot dopamine agonists, fall under Medicare Part D. These drug classes are recognized by CMS as commonly prescribed for the Medicare population, so Part D plans generally include them on their formularies.
Where your specific medication lands on a plan’s tier structure determines your copay. Part D formularies use ascending tiers, with Tier 1 being the lowest cost. Generic carbidopa-levodopa, one of the most widely used Parkinson’s drugs, typically sits on a lower tier with modest copays. Newer or brand-name medications may be placed on higher tiers with steeper cost-sharing. Plans can also designate a specialty tier for very high-cost drugs, where cost-sharing can reach 25% to 33% of the drug’s price.
Because each Part D plan designs its own formulary, the exact tier placement and copay for a given Parkinson’s medication varies from plan to plan. If a drug you need isn’t on your plan’s formulary or is placed on a high tier, you can request a formulary exception or tiering exception through your plan. One important detail: plans are allowed to exempt their specialty tier from these tiering exception requests.
Physical, Occupational, and Speech Therapy
Therapy services are a cornerstone of Parkinson’s management. Medicare Part B covers physical therapy to help with balance, gait, and fall prevention; occupational therapy for daily tasks like dressing and eating; and speech-language pathology for the voice and swallowing problems that often develop as the disease progresses.
For 2025, Medicare applies a threshold of $2,410 for physical therapy and speech therapy combined, and a separate $2,410 threshold for occupational therapy. You can receive services up to these amounts under standard billing. Beyond that point, your therapist must document that continued treatment is medically necessary. Claims submitted above these thresholds without the proper documentation are denied, so it’s worth keeping track of where you stand if you’re receiving ongoing therapy throughout the year.
Deep Brain Stimulation Surgery
Medicare covers deep brain stimulation (DBS) for Parkinson’s when specific clinical criteria are met. This is a surgical procedure where electrodes are implanted in targeted areas of the brain to help control movement symptoms. To qualify, you must have a confirmed diagnosis based on at least two cardinal Parkinson’s features, be responsive to levodopa with clear “on” periods, and still experience persistent disabling symptoms or medication side effects like dyskinesias and motor fluctuations despite optimal drug therapy.
Medicare requires that a physician specializing in movement disorders be involved in both selecting candidates for the procedure and managing follow-up care afterward. The surgery must be performed at a medical center equipped with brain imaging (MRI or CT) for surgical targeting and the full support services needed to handle potential complications. Coverage does not extend to patients with non-idiopathic Parkinson’s (sometimes called “Parkinson’s Plus” syndromes) or those with significant cognitive impairment, dementia, or depression that would interfere with benefiting from the procedure.
Specialized Drug Delivery for Advanced Disease
For people with advanced Parkinson’s whose symptoms are no longer well controlled on oral medications, Medicare covers carbidopa-levodopa enteral suspension (marketed as Duopa). This system uses a portable pump to deliver medication directly into the small intestine through a surgically placed tube for 16 continuous hours per day. The External Infusion Pumps policy provides the coverage pathway for this treatment. It’s typically considered alongside DBS as one of the main options when oral therapy alone isn’t enough, though it does require surgery for tube placement and doesn’t address overnight symptoms.
Mobility Aids and Durable Medical Equipment
Medicare Part B covers walkers, canes, manual wheelchairs, power wheelchairs, and scooters when they’re medically necessary for use in your home. The qualification process follows a step-by-step logic based on your functional ability. If you can’t safely use a cane or walker but have sufficient upper body strength, you may qualify for a manual wheelchair. If you can’t operate a manual wheelchair, a power scooter may be covered. If neither a manual wheelchair nor a scooter works in your home environment, a power wheelchair becomes an option.
For power wheelchairs and scooters, you’ll need a face-to-face exam with your doctor, who then submits a written order explaining your medical need and confirming you can safely operate the device. Your doctor or the equipment supplier must also verify that the device works within your home, meaning it fits through doorways and can be used in your living space. Both your treating physician and the equipment supplier must accept Medicare assignment for the claim to be covered. After the Part B deductible, you pay 20% of the approved amount.
Home Health Services
As Parkinson’s progresses, many people reach a point where leaving home becomes difficult. Medicare covers home health services if you’re considered “homebound,” meaning you need help from another person, a mobility device, or special transportation to leave, or that leaving home requires a major effort due to your condition. Many people with advanced Parkinson’s meet this standard.
Covered services include part-time or intermittent skilled nursing care, physical therapy, occupational therapy, and speech therapy delivered in your home. A home health aide can also assist with personal care. In most cases, skilled nursing and aide services combined can total up to 8 hours per day, with a maximum of 28 hours per week. For short periods, that cap can increase to 35 hours per week if your care team determines it’s necessary. Home health services have no copay or deductible when provided by a Medicare-certified agency under a doctor’s plan of care.
Hospice Care
Medicare covers hospice care when a physician certifies that life expectancy is six months or less if the disease follows its normal course. Parkinson’s is specifically listed among the neurological conditions considered when evaluating hospice eligibility. The assessment looks at functional decline, including a performance status score below 70% and dependence on help for at least two daily activities such as walking, dressing, bathing, eating, using the bathroom, or maintaining continence.
Hospice coverage under Medicare Part A is comprehensive. It includes pain management, symptom control, nursing visits, medications related to the terminal diagnosis, medical equipment, and support for family caregivers. Importantly, meeting a specific checklist of clinical criteria isn’t strictly required. The core requirement is that documentation supports the six-month prognosis, and the clinical guidelines carry significant weight during any coverage review.